Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

67.3K
Overview
67.3K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

460
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
460
Tissue Transplantation01:24

Tissue Transplantation

341
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
341
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

911
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
911

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

[Use of teduglutide in short bowel syndrome in infants, children and adolescents: Position paper of the working group "Chronic intestinal failure" of the Society for Paediatric Gastroenterology and Nutrition (GPGE)].

Zeitschrift fur Gastroenterologie·2026
Same author

Feasibility and workflow analysis of confocal microscopy in robot-assisted prostatectomy.

BJU international·2026
Same author

Newborn Screening Alone Cannot Prevent Most Cases of Severe Vitamin B12 Deficiency in the First Year of Life.

Nutrients·2025
Same author

Extraskeletal osteosarcoma harboring ETV6::NTRK3 fusion treated successfully with larotrectinib: a case study.

Communications medicine·2025
Same author

Tumor-Infiltrating Lymphocytes in Breast and Female Genital Tract Cancers: Overlooked Potential and Unexplored Frontiers.

Cancer medicine·2025
Same author

Comparative analysis of hydrogen breath test devices for the diagnosis of carbohydrate malabsorption: fructose tests lack reliability.

European journal of gastroenterology & hepatology·2025

相关实验视频

Updated: Jun 8, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K

兰格汉斯细胞囊细胞分裂还是急性细胞排斥?

Andreas Entenmann1, Hubert Kogler2, Wolf-Dietrich Huber3

  • 1Department of Pediatrics I, Innsbruck Medical University, Innsbruck, Austria.

Pediatric transplantation
|November 5, 2024
PubMed
概括

免疫组织化学标记物CD1a和CD207在肝移植后损坏的胆道中识别兰格汉斯细胞 (LC). 然而,这些标记物并不特定于朗格汉斯细胞囊细胞瘤 (LCH) 复发,表明它们的存在本身不足以诊断.

关键词:
CD1a 是一个CD1a.兰格拉汉斯细胞基细胞分裂急性细胞排斥 细胞排斥兰格林兰格林兰格林兰格林肝脏 肝脏 肝脏 肝脏 肝脏 肝脏

更多相关视频

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.5K

相关实验视频

Last Updated: Jun 8, 2025

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.3K
HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
07:18

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL

Published on: April 11, 2011

15.4K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.5K

科学领域:

  • 免疫病理学 免疫病理学
  • 移植医学 移植医学 移植医学
  • 在瘤学瘤学.

背景情况:

  • 朗格汉斯细胞囊细胞症 (LCH) 是一种罕见的疾病,涉及树突细胞透,可能导致器官功能障碍.
  • 一名肝移植接受者患上了胆血管病,这引发了关于观察到的朗格汉斯细胞 (LC) 是否表明急性细胞排斥 (ACR) 或复发性LCH.的问题.

研究的目的:

  • 在肝移植中,要区分急性细胞排斥 (ACR) 和复发的朗格汉斯细胞囊细胞症 (LCH).
  • 评估CD1a和CD207免疫染的特异性,用于诊断移植后胆管病变中复发性LCH.

主要方法:

  • 使用CD1a和CD207抗体进行免疫组织化学分析,对肝移植患者进行了免疫组织化学分析,该患者怀疑LCH复发.
  • 对14名急性细胞排斥 (ACR) 患者的其他样本进行了比较分析.

主要成果:

  • 在15个样本中,80%显示了CD1a和/或CD207.7的阳性染色.
  • 四个样本 (26.7%),包括索引案例,在胆道表皮和周围组织中表现出两种标记物的同时表达.
  • 六个样本 (40%) 显示只有一个标记物的染色.

结论:

  • 针对CD1a和CD207的免疫抑制可以识别受损胆道中的朗格汉斯细胞 (LC),即使没有疑似LCH.
  • CD1a和CD207的共同表达并不特定于肝移植中的复发性LCH.
  • 仅仅CD1a+/CD207+细胞的存在不足以证实在移植后肝脏疾病的背景下复发的LCH.